Today: 19 March 2026
Subscribe
Browse Category

LSE:BP 30 January 2026 - 13 March 2026

UK Stock Market Today: FTSE 100 Slides as Oil Jumps, BoE Cut Bets Take Another Hit

UK Stock Market Today: FTSE 100 Slides as Oil Jumps, BoE Cut Bets Take Another Hit

London’s FTSE 100 dropped 0.7% in early trade Thursday as Brent crude topped $100 a barrel following new Gulf shipping attacks. Travel firm On the Beach suspended its profit forecast, citing weaker holiday demand tied to Middle East conflict. Legal & General shares fell 5% after missing profit targets. TP ICAP rose 3.5% on stronger trading results.
12 March 2026
···········
BP PLC Shares Rise as Oil Prices Spike, but Traders Still Bet the Windfall Fades

BP PLC Shares Rise as Oil Prices Spike, but Traders Still Bet the Windfall Fades

BP shares rose 2.2% in London Monday as Brent crude briefly hit $119.50 a barrel, the highest since 2022, following the U.S.-Israeli war on Iran and disruption in the Strait of Hormuz. BP paused its $750 million share buyback last month to focus on debt reduction, with net debt at $22 billion. Global bonds fell as traders shifted from expecting Bank of England rate cuts to a possible hike by December.
9 March 2026
···
UK stock market today: FTSE 100 pares early slump as oil shock hits London shares

UK stock market today: FTSE 100 pares early slump as oil shock hits London shares

FTSE 100 closed down 0.3% and FTSE 250 fell 1.6% after Brent crude surged over 25% to $119.50 a barrel amid the U.S.-Iran war. UK gilt yields jumped as traders shifted bets toward a possible Bank of England rate hike. Sterling weakened, while energy stocks like Shell and BP rose. Homebuilders and property shares led declines, with Persimmon down 5.5%.
9 March 2026
········
Shell Plc Signs Venezuela Oil and Gas Deals, Putting Dragon Gas Project Back in Play

Shell Plc Signs Venezuela Oil and Gas Deals, Putting Dragon Gas Project Back in Play

Shell signed oil and gas agreements with Venezuela to develop the offshore Dragon field, aiming for first gas exports to Trinidad by Q3 2027, according to Trinidad's Energy Minister. The deal follows new U.S. licenses easing sanctions and includes technical partnerships with VEPICA, KBR, and Baker Hughes. Dragon holds about 4.5 trillion cubic feet of gas. Atlantic LNG in Trinidad shipped 9 million metric tons in 2025, below its 12 million capacity.
6 March 2026
····
Oil prices spike past $84 as Iran war shuts Hormuz, rattles global stocks

Oil prices spike past $84 as Iran war shuts Hormuz, rattles global stocks

Oil prices jumped over 3% Wednesday as the U.S.-Israeli war on Iran shut the Strait of Hormuz, halting tanker traffic and stranding about 200 vessels. European gas prices soared more than 50% Monday, prompting an emergency EU meeting, while South Korea’s KOSPI index plunged 12.06%, its steepest drop ever. Global stocks fell sharply as investors sought safe havens. Shipping costs and war-risk premiums surged in the Gulf region.
4 March 2026
····
Shell stock price in focus: oil drops 1% ahead of London open, Iran talks loom

Shell stock price in focus: oil drops 1% ahead of London open, Iran talks loom

Shell shares closed at 2,940.5 pence Friday in London, with traders watching Brent crude, which fell 1.21% to $70.89 a barrel early Monday amid U.S.-Iran talks and new tariff headlines. Goldman Sachs raised its 2026 Brent forecast to $60 but expects a surplus this year. Shell’s $3.5 billion buyback runs through May 1. The company’s next dividend payment is set for March 30.
23 February 2026
····
BP share price: BP stock in focus before London open after buyback pause

BP share price: BP stock in focus before London open after buyback pause

BP suspended its share buyback program and reported a 2025 underlying replacement cost profit of $7.5 billion, keeping its quarterly dividend at 8.32 cents. Shares fell as much as 7% after $4 billion in charges on renewables and biogas assets, while net debt dropped to $22 billion. Brent crude rose to $69.67 a barrel amid U.S.-Iran tensions. OPEC forecast weaker demand for OPEC+ crude in the second quarter.
12 February 2026
·
BP stock price slides as buybacks stop — debt cuts and new CEO take over the story

BP stock price slides as buybacks stop — debt cuts and new CEO take over the story

BP shares dropped 5.2% in London after the company paused its $750 million quarterly share buyback and shifted excess cash to debt reduction and oil and gas projects. Fourth-quarter underlying replacement cost profit was $1.54 billion, with net debt cut to $22 billion. The move comes ahead of a CEO handover in April and amid ongoing asset sales, including Castrol.
10 February 2026
··
Imperial Brands share price drops 1% as FTSE slips and dividend date nears

Imperial Brands share price drops 1% as FTSE slips and dividend date nears

Imperial Brands shares fell 1.1% to 3,258 pence in early London trading, near session lows, as tobacco stocks tracked a weaker FTSE 100. British American Tobacco dropped 1.5%. BP’s paused buybacks weighed on the market, sharpening focus on dividends and balance sheets. Investors are watching Imperial’s Feb. 19 ex-dividend date and upcoming trading update.
10 February 2026
·····
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
7 February 2026
····
1 2 3 4

Stock Market Today

  • Pelthos Therapeutics Q4 Loss Narrower Than Expected, Revenue Beats Estimates
    March 19, 2026, 9:26 AM EDT. Pelthos Therapeutics Inc. (PTHS) reported a Q4 loss of $2.83 per share, narrower than the Zacks Consensus Estimate of a $3.95 loss and improved from a $3.2 loss last year. The company posted $9.39 million in revenue, beating estimates by 3.78%, marking its first revenue in a year. Despite this, shares have fallen 22.3% year-to-date, underperforming the S&P 500. The stock holds a Zacks Rank #5 (Strong Sell) reflecting unfavorable earnings outlook and estimate revisions. Consensus estimates predict a loss of $3.84 per share next quarter on $9.86 million revenue and a $10.80 loss for the fiscal year on $62.29 million revenue. Market performance depends on management commentary and industry trends within the Medical - Biomedical and Genetics sector, currently ranked in the bottom 43% of Zacks industries.
Go toTop